Diagnostics

LIVERFASt DR Diabetes

Product Description

Type 2 Diabetes is more than 2-fold higher in individuals with NAFLD and often evolves with normal liver enzymes.

LIVERFAStTM accurately identifies severe fibrosis and cirrhosis in both patients with or without type 2 diabetes irrespective of liver enzyme levels.

NASH related cirrhosis is disproportionately high in those with type 2 diabetes and is now on a trajectory to become the most common indication for liver transplantation in the U.S.

LIVERFAStTM accurately identifies cirrhosis in subjects with all biochemistry inside the normal laboratory range.

Product Brochure

Interested in this product?

Request a call-back

Product Description

HEMOdialert™ – For added confidence and safety during Hemodialysis

The HEMOdialert™ with the HEMOsensor™ was designed and developed in consultation with dialysis clinicians to detect blood loss from the fistula site.

HEMOdialysis and the need for a line disconnect alarm.

Estimates from epidemiological surveys indicate that 1.5 million patients worldwide require dialysis, and 90% of those have hemodialysis. Each year an additional 81,000 patients are added to that number.

Hemodialysis as the preferred method is increasing in popularity, and more clinics are now offering patients home dialysis rather than coming into a clinic.

Occasionally during hemodialysis the vein needle connecting the blood line from the dialysis machine may disconnect from the fistula site. This can result in blood leak. While the dialysis machine itself may detect line disconnect due to pressure drop, and trigger an alarm, these alarms are not reliable.

Detect dangerous fistula disconnections

Although it is not a common event, line disconnect can have fatal or life threatening consequences (Sandroni, 2005). This has been a matter of concern for clinicians carrying out hemodialysis and reported in clinical publications. (Lindley, 2005)

Anzacare, with a 25 year history of developing patented moisture detectors and alarm systems, was contacted by clinics in USA, Canada, Australia and the UK with a view to developing a product to detect blood leak due to line disconnect.

Over 5 years Anzacare developed the HEMOdialert™ product with feedback from clinicians and independent testing. Anzacare now supplies hospitals and clinics with the HEMOdialert™, an effective and reasonably priced blood leak detection alarm and sensor that can give additional confidence to patients undergoing hemodialysis.

Training Materials

User Guide

Product Brochure